Prevention strategies of cervical cancer in the HPV vaccine era

被引：47

作者：

Bosch, Xavier

Harper, Diane

机构：

[1] Hosp Llobregat, Inst Catala Oncol, Epidemiol & Canc Registrat Unit, Barcelona 70890, Spain

[2] Dartmouth Med Sch, Dept Family & Community Med, Dept Obstet & Gynecol, Hanover, NH USA

来源：

GYNECOLOGIC ONCOLOGY | 2006年 / 103卷 / 01期

关键词：

cervical cancer; prevention; screening; vaccine; HPV; prophylactic; PAP smear;

D O I：

10.1016/j.ygyno.2006.07.019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：21 / 24

页数：4

共 9 条

[1] [Anonymous], 2005, IARC HDB CANC PREV C
[2] A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
Ault, KA
Giuliano, AR
Edwards, RP
Tamms, G
Kim, LL
Smith, JF
Jansen, KU
Allende, M
Taddeo, FJ
Skulsky, DM
Barr, E
[J]. VACCINE, 2004, 22 (23-24) : 3004 - 3007
[3] Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Cuzick, Jack
Clavel, Christine
Petry, Karl-Ulrich
Meijer, Chris J. L. M.
Hoyer, Heike
Ratnam, Samuel
Szarewski, Anne
Birembaut, Philippe
Kulasingam, Shalini
Sasieni, Peter
Iftner, Thomas
[J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) : 1095 - 1101
[4] Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women
Fife, KH
Wheeler, CM
Koutsky, LA
Barr, E
Brown, DR
Schiff, MA
Kiviat, NB
Jansen, KU
Barber, H
Smith, JF
Tadesse, A
Giacoletti, K
Smith, PR
Suhr, G
Johnson, DA
[J]. VACCINE, 2004, 22 (21-22) : 2943 - 2952
[5] Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Harper, DM
Franco, EL
Wheeler, C
Ferris, DG
Jenkins, D
Schuind, A
Zahaf, T
Innis, B
Naud, P
De Carvalho, NS
Roteli-Martins, CM
Teixeira, J
Blatter, MM
Korn, AP
Quint, W
Dubin, G
[J]. LANCET, 2004, 364 (9447) : 1757 - 1765
[6] Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Harper, DM
Franco, EL
Wheeler, CM
Moscicki, AB
Romonowski, B
Roteli-Martins, CM
Jenkins, D
Schuind, A
Clemens, SAC
Dubin, G
[J]. LANCET, 2006, 367 (9518) : 1247 - 1255
[7] A controlled trial of a human papillomavirus type 16 vaccine
Koutsky, LA
Ault, KA
Wheeler, CM
Brown, DR
Barr, E
Alvarez, FB
Chiacchierini, LM
Jansen, KU
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) : 1645 - 1651
[8] Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 L1 capsomers
Orozco, JJ
Carter, JJ
Koutsky, LA
Galloway, DA
[J]. JOURNAL OF VIROLOGY, 2005, 79 (15) : 9503 - 9514
[9] Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa, LL
Costa, RLR
Petta, CA
Andrade, RP
Ault, KA
Giuliano, AR
Wheeler, CM
Koutsky, LA
Malm, C
Lehtinen, M
Skjeldestad, FE
Olsson, SE
Steinwall, M
Brown, DR
Kurman, R
Ronnett, BM
Stoler, MH
Ferenczy, A
Harper, DM
Tamms, GM
Yu, J
Lupinacci, L
Railkar, R
Taddeo, FJ
Jansen, KU
Esser, MT
Sings, HL
Saah, AJ
Lupinacci, L
[J]. LANCET ONCOLOGY, 2005, 6 (05) : 271 - 278

← 1 →